Lars Fruergaard Jorgensen
Chief Executive Officer bei NOVO NORDISK A/S
Profil
Lars Fruergaard Jrgensen ist Vizepräsident der European Federation of Pharmaceutical Industries & Assns, stellvertretender Vorsitzender des Aufsichtsrats von Carlsberg A/S, Mitglied des Aufsichtsrats von Carlsberg Breweries A/S, Präsident und Chief Executive Officer von Novo Nordisk Ltd, Präsident und Chief Executive Officer von Novo Nordisk A/S und Vorsitzender von Harno Invest A/S. Er ist Mitglied des Board of Directors bei Carlsberg A/S und Carlsberg Breweries A/S. Herr Jrgensen war zuvor als Aufsichtsratsmitglied bei Innate Pharma SA, als Vice President-Finance & Information Technology bei Novo Nordisk Pharmaceutical SAS und als Vorsitzender bei NNE Pharmaplan A/S tätig. Außerdem war er Vorstandsmitglied bei ZymoGenetics, Inc. und NNIT A/S. Er erhielt seinen Hochschulabschluss an der Universität Aarhus.
Aktive Positionen von Lars Fruergaard Jorgensen
| Unternehmen | Position | Beginn |
|---|---|---|
| NOVO NORDISK A/S | Chief Executive Officer | 01.01.2017 |
Harno Invest A/S
 Harno Invest A/S Financial ConglomeratesFinance Harno Invest A/S provides investment and financial services. The company was founded in 2002 and is located in Copenhagen, Denmark | Chairman | 25.01.2011 |
Novo Nordisk Ltd.
 Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom. | Chief Executive Officer | 01.09.2004 |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Corporate Officer/Principal | 01.01.2021 |
Ehemalige bekannte Positionen von Lars Fruergaard Jorgensen
| Unternehmen | Position | Ende |
|---|---|---|
| NNIT A/S | Director/Board Member | 06.03.2015 |
| INNATE PHARMA | Director/Board Member | 04.03.2013 |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Director/Board Member | 08.10.2010 |
Novo Nordisk SAS
 Novo Nordisk SAS Pharmaceuticals: MajorHealth Technology Novo Nordisk SAS manufactures pharmaceutical drugs. It produces and sells medicines for the treatment of diabetes, haemophilia, and hormonal disease. The company was founded in 1959 and is headquartered in Paris, France. | Director of Finance/CFO | 01.01.2004 |
Carlsberg Breweries A/S
 Carlsberg Breweries A/S Beverages: AlcoholicConsumer Non-Durables Carlsberg Breweries A/S engages in the production and marketing of beer and soft drinks. The firm's brands include Afsana, Backyard Brew, CELIA, Dahls, and Eriksberg. It operates through the following geographical segments: Western Europe; Asia; Eastern Europe; and Central and Eastern Europe. The company was founded by Jacob Christian Jacobsen in 1847 and is headquartered in Copenhagen, Denmark. | Director/Board Member | - |
Ausbildung von Lars Fruergaard Jorgensen
| University of Aarhus | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| CARLSBERG A/S | Consumer Non-Durables |
| INNATE PHARMA | Health Technology |
| NNIT A/S | Technology Services |
| Private Unternehmen | 7 |
|---|---|
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
Carlsberg Breweries A/S
Carlsberg Breweries A/S Beverages: AlcoholicConsumer Non-Durables Carlsberg Breweries A/S engages in the production and marketing of beer and soft drinks. The firm's brands include Afsana, Backyard Brew, CELIA, Dahls, and Eriksberg. It operates through the following geographical segments: Western Europe; Asia; Eastern Europe; and Central and Eastern Europe. The company was founded by Jacob Christian Jacobsen in 1847 and is headquartered in Copenhagen, Denmark. | Consumer Non-Durables |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Commercial Services |
Novo Nordisk SAS
Novo Nordisk SAS Pharmaceuticals: MajorHealth Technology Novo Nordisk SAS manufactures pharmaceutical drugs. It produces and sells medicines for the treatment of diabetes, haemophilia, and hormonal disease. The company was founded in 1959 and is headquartered in Paris, France. | Health Technology |
Novo Nordisk Ltd.
Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom. | Health Services |
Harno Invest A/S
Harno Invest A/S Financial ConglomeratesFinance Harno Invest A/S provides investment and financial services. The company was founded in 2002 and is located in Copenhagen, Denmark | Finance |
NNE Pharmaplan A/S
 NNE Pharmaplan A/S Pharmaceuticals: MajorHealth Technology NNE Pharmaplan A/S produces pharmaceutical products. The company is based in Soborg, Denmark. | Health Technology |
